Efficacy of Abhragarbha Pottali in the management of bronchial asthma

Evaluation of clinical efficacy of Abhragarbha Pottali prepared by Shashti Puta Abhraka Bhasma in the management of Tamaka Shwasa(bronchial asthma)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/051928

Enrollment

Registered

2023-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients having signs and symptoms of Tamaka Shwasa described in Ayurvedic texts such as- 1 Pinasa 2 Gurghuraka 3 Greeva Shirisha Sangruhya 4 Ativativra Vega Shwasa 5 Kanthodhvamsa 6 Asinolabahte Saukhyama 2)symptoms mentioned in modern texts such as- 1wheezing, 2coughing 3shortness of breath 3)Uncomplicated cases of Tamaka Shwasa 4)Patients willing to participate in trial

Exclusion criteria

Exclusion criteria: 1)Age below 18 years and above 60 years 2)Pregnant and lactating women 3)Patients having complications like- 1 cor-pulmonale 2 pulmonary TB 3 emphysema 4 pneumonia 5 cystic fibrosis 6 malignancy 7 severe anaemia 8 renal failure 9 congestive cardiac failure. 10 Patients suffering from malignant and accelerated hypertension 11 coronary artery disease 12 uncontrolled diabetes. 4)Patient undergoing regular treatment for any other severe illness and also patient on prolonged corticosteroid use

Design outcomes

Primary

Measure	Time frame
Improvement in cardinal symptomsTimepoint: Baseline, From 1st week to 12 weeks weekly	—

Secondary

Measure	Time frame
Improvement in Pulmonanary Function test, ACQ, ACT scoresTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Prashant Bedarkar

ITRA, Jamnagar

drprashantbedarkar@gmail.com8128217370

Outcome results